Product
Pneumococcal 13-valent polysaccharide conjugate vaccine
1 clinical trial
1 indication
Indication
Volunteers (Meningococcal Infection)Clinical trial
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Using a 1+1 Schedule in a National Immunization Schedule Having a Meningococcal Group B Vaccine as Standard of CareStatus: Completed, Estimated PCD: 2022-12-05